» Articles » PMID: 24586162

The Chlamydia Trachomatis Type III Secretion Chaperone Slc1 Engages Multiple Early Effectors, Including TepP, a Tyrosine-phosphorylated Protein Required for the Recruitment of CrkI-II to Nascent Inclusions and Innate Immune Signaling

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2014 Mar 4
PMID 24586162
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia trachomatis, the causative agent of trachoma and sexually transmitted infections, employs a type III secretion (T3S) system to deliver effector proteins into host epithelial cells to establish a replicative vacuole. Aside from the phosphoprotein TARP, a Chlamydia effector that promotes actin re-arrangements, very few factors mediating bacterial entry and early inclusion establishment have been characterized. Like many T3S effectors, TARP requires a chaperone (Slc1) for efficient translocation into host cells. In this study, we defined proteins that associate with Slc1 in invasive C. trachomatis elementary bodies (EB) by immunoprecipitation coupled with mass spectrometry. We identified Ct875, a new Slc1 client protein and T3S effector, which we renamed TepP (Translocated early phosphoprotein). We provide evidence that T3S effectors form large molecular weight complexes with Scl1 in vitro and that Slc1 enhances their T3S-dependent secretion in a heterologous Yersinia T3S system. We demonstrate that TepP is translocated early during bacterial entry into epithelial cells and is phosphorylated at tyrosine residues by host kinases. However, TepP phosphorylation occurs later than TARP, which together with the finding that Slc1 preferentially engages TARP in EBs leads us to postulate that these effectors are translocated into the host cell at different stages during C. trachomatis invasion. TepP co-immunoprecipitated with the scaffolding proteins CrkI-II during infection and Crk was recruited to EBs at entry sites where it remained associated with nascent inclusions. Importantly, C. trachomatis mutants lacking TepP failed to recruit CrkI-II to inclusions, providing genetic confirmation of a direct role for this effector in the recruitment of a host factor. Finally, endocervical epithelial cells infected with a tepP mutant showed altered expression of a subset of genes associated with innate immune responses. We propose a model wherein TepP acts downstream of TARP to recruit scaffolding proteins at entry sites to initiate and amplify signaling cascades important for the regulation of innate immune responses to Chlamydia.

Citing Articles

Effect of tryptophan starvation on inclusion membrane composition and chlamydial-host interactions.

Riffaud-Widner C, Widner R, Ouellette S, Rucks E Infect Immun. 2025; 93(2):e0053224.

PMID: 39804088 PMC: 11834466. DOI: 10.1128/iai.00532-24.


-driven ISG15 expression dampens the immune response of epithelial cells independently of ISGylation.

Wu Y, Liu C, Tang C, Niragire B, Levy-Zauberman Y, Adapen C mBio. 2024; 15(11):e0240124.

PMID: 39345209 PMC: 11559041. DOI: 10.1128/mbio.02401-24.


Insights into Chlamydia Development and Host Cells Response.

Yang S, Zeng J, Yu J, Sun R, Tuo Y, Bai H Microorganisms. 2024; 12(7).

PMID: 39065071 PMC: 11279054. DOI: 10.3390/microorganisms12071302.


Identification of homologs of the Chlamydia trachomatis effector CteG reveals a family of Chlamydiaceae type III secreted proteins that can be delivered into host cells.

Pereira I, da Cunha M, Leal I, Luis M, Goncalves P, Goncalves C Med Microbiol Immunol. 2024; 213(1):15.

PMID: 39008129 PMC: 11249467. DOI: 10.1007/s00430-024-00798-9.


Dynamin-dependent entry of Chlamydia trachomatis is sequentially regulated by the effectors TarP and TmeA.

Romero M, Carabeo R Nat Commun. 2024; 15(1):4926.

PMID: 38858371 PMC: 11164928. DOI: 10.1038/s41467-024-49350-6.


References
1.
Hower S, Wolf K, Fields K . Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol. 2009; 72(6):1423-37. PMC: 2997736. DOI: 10.1111/j.1365-2958.2009.06732.x. View

2.
Samudrala R, Heffron F, McDermott J . Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog. 2009; 5(4):e1000375. PMC: 2668754. DOI: 10.1371/journal.ppat.1000375. View

3.
Thomas N, Ma I, Prasad M, Rafuse C . Expanded roles for multicargo and class 1B effector chaperones in type III secretion. J Bacteriol. 2012; 194(15):3767-73. PMC: 3416526. DOI: 10.1128/JB.00406-12. View

4.
Reich N . A death-promoting role for ISG54/IFIT2. J Interferon Cytokine Res. 2013; 33(4):199-205. PMC: 3624773. DOI: 10.1089/jir.2012.0159. View

5.
Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T . Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature. 1996; 379(6564):466-9. DOI: 10.1038/379466a0. View